HIGH Stock Overview
Operates as a medical cannabis company in Europe. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 5/6 |
| Past Performance | 4/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
My Notes
Capture your thoughts, links and company narrative
Cantourage Group SE Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €5.15 |
| 52 Week High | €11.00 |
| 52 Week Low | €4.12 |
| Beta | -0.37 |
| 1 Month Change | 12.94% |
| 3 Month Change | 1.98% |
| 1 Year Change | -27.67% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -68.40% |
Recent News & Updates
Shareholder Returns
| HIGH | DE Pharmaceuticals | DE Market | |
|---|---|---|---|
| 7D | -9.6% | -3.9% | -2.6% |
| 1Y | -27.7% | -15.2% | 7.1% |
Return vs Industry: HIGH underperformed the German Pharmaceuticals industry which returned -15.2% over the past year.
Return vs Market: HIGH underperformed the German Market which returned 7.1% over the past year.
Price Volatility
| HIGH volatility | |
|---|---|
| HIGH Average Weekly Movement | 7.7% |
| Pharmaceuticals Industry Average Movement | 5.4% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in DE Market | 11.6% |
| 10% least volatile stocks in DE Market | 2.5% |
Stable Share Price: HIGH's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: HIGH's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2019 | 625 | Philip Schetter | www.cantourage.com |
Cantourage Group SE operates as a medical cannabis company in Europe. It offers dried flowers, extracts, dronabinol products, and pharma-grade cannabidiol products. The company was founded in 2019 and is based in Kleinmachnow, Germany.
Cantourage Group SE Fundamentals Summary
| HIGH fundamental statistics | |
|---|---|
| Market cap | €64.22m |
| Earnings (TTM) | €221.14k |
| Revenue (TTM) | €1.96m |
290.4x
P/E Ratio32.7x
P/S RatioIs HIGH overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| HIGH income statement (TTM) | |
|---|---|
| Revenue | €1.96m |
| Cost of Revenue | €0 |
| Gross Profit | €1.96m |
| Other Expenses | €1.74m |
| Earnings | €221.14k |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.018 |
| Gross Margin | 100.00% |
| Net Profit Margin | 11.27% |
| Debt/Equity Ratio | 0% |
How did HIGH perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/20 00:11 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Cantourage Group SE is covered by 2 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Tim Kruse | Montega AG |
| Christian Sandherr | NuWays AG |